Federal study will test combination of remdesivir and multiple sclerosis in coronavirus patients – Daily Mail

Researchers will compare remdesivir (pictured(and a placebo to remdesivir and beta interferon, which is approved to treat multiple sclerosis, has anti-inflammatory properties and has been shown to stop replication of viruses like SARS

A federal study looking at the antiviral drug remdesivir as a treatment for the novel coronavirus is entering a new phase.

In April, the National Institutes of Health (NIH) released results from a study that found the medication helped patients recover 31 percent faster.

Now, researchers want to see if adding another drug could improve the effects of remdesivir and shorten recovery time even further, reported The New York Times.

Click here to read full article https://www.dailymail.co.uk/health/article-8640889/Federal-study-test-combination-remdesivir-multiple-sclerosis-coronavirus-patients.html

Font Resize